TMPRSS2: ERG expression in prostate cancer-Imaging and clinicopathological correlations

被引：0
|
作者：
Fasulo, Vittorio
Lazzeri, Massimo
Corbetta, Marinella
Paciotti, Marco
Maffei, Davide
Solda, Giulia
Domanico, Luigi
Frego, Nicola
Regis, Federica
Diana, Pietro
Asselta, Rosanna
Buffi, Nicolo'
Casale, Paolo
Saita, Alberto
Chiereghin, Chiara
Lughezzani, Giovanni
Zuradelli, Monica
Hurle, Rodolfo
Duga, Stefano
Guazzoni, Giorgio Ferruccio
机构：
[1] IRCCS Humanitas Clin & Res Hosp, Rozzano, Italy
[2] IRCCS Humanitas Clin & Res Ctr, Rozzano, Italy
[3] IRCCS, Humanitas Canc Ctr, Rozzano, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
284
引用
收藏
页数：1
相关论文
共 50 条
  • [31] URINE MEASUREMENT OF TMPRSS2:ERG FOR THE EARLY DETECTION OF SIGNIFICANT PROSTATE CANCER
    Sakamoto, Kyoko
    Aubin, Sheila
    Tomlins, Scott
    Kane, Christopher
    Downs, Tracy
    Silberstein, Jonathan
    Siddiqui, Javed
    Penabella, Yvonne
    Fradet, Yves
    Rittenhouse, Harry
    Groskopf, Jack
    Chinnaiyan, Arul
    JOURNAL OF UROLOGY, 2010, 183 (04): : E824 - E824
  • [32] URINE MEASUREMENT OF TMPRSS2: ERG FOR THE EARLY DETECTION OF SIGNIFICANT PROSTATE CANCER
    Groskopf, J.
    Aubin, S. M. J.
    Tomlins, S. A.
    Sakamoto, K.
    Silberstein, J.
    Siddiqui, J.
    Penabella, Y.
    Fradet, Y.
    Rittenhouse, H.
    Chinnaiyan, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 275 - 276
  • [33] Confirmation of the Association of TMPRSS2(exon 0):ERG Expression and a Favorable Prognosis of Primary Prostate Cancer
    Boormans, Joost L.
    Porkka, Kati
    Visakorpi, Tapio
    Trapman, Jan
    EUROPEAN UROLOGY, 2011, 60 (01) : 183 - 184
  • [34] Expression of TMPRSS2 ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression
    Nam, Robert K.
    Sugar, Linda
    Wang, Zhenghui
    Yang, Wenyi
    Kitching, Richard
    Klotz, Laurence H.
    Venkateswaran, Vasundara
    Narod, Steven A.
    Seth, Arun
    CANCER BIOLOGY & THERAPY, 2007, 6 (01) : 40 - 45
  • [35] TMPRSS2: ERG rearrangement is an independent marker of good prognosis in prostate cancer
    Saramaeki, O. R.
    Harjula, A. E.
    Martkainen, P. M.
    Vessella, R. L.
    Tammela, T. L. J.
    Visalkorpi, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 253 - 253
  • [36] TMPRSS2:ERG Fusion Gene and Androgen Ablation Therapy in Prostate Cancer
    Baldi, Elisabetta
    Bonaccorsi, Lorella
    Nesi, Gabriella
    Serni, Sergio
    Forti, Gianni
    Luzzatto, Lucio
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (07) : 964 - U24
  • [37] Association of physical activity with risk of prostate cancer defined by TMPRSS2:ERG
    Pernar, Claire H.
    Ebot, Ericka M.
    Pettersson, Andreas
    Graff, Rebecca E.
    Ahearn, Thomas U.
    Gonzalez-Feliciano, Amparo G.
    Markt, Sarah C.
    Wilson, Kathryn M.
    Finn, Stephen
    Fiorentino, Michelangelo
    Giovannucci, Edward L.
    Mucci, Lorelei A.
    CANCER RESEARCH, 2017, 77
  • [38] Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression
    Nam, Robert K.
    Sugar, Linda M.
    Klotz, Laurence H.
    Venkateswaran, Vasundara
    Seth, Arun
    JOURNAL OF UROLOGY, 2007, 177 (04): : 467 - 468
  • [39] Height, Obesity, and the Risk of TMPRSS2: ERG-Defined Prostate Cancer
    Graff, Rebecca E.
    Ahearn, Thomas U.
    Pettersson, Andreas
    Ebot, Ericka M.
    Gerke, Travis
    Penney, Kathryn L.
    Wilson, Kathryn M.
    Markt, Sarah C.
    Pernar, Claire H.
    Gonzalez-Feliciano, Amparo G.
    Song, Mingyang
    Lis, Rosina T.
    Schmidt, Daniel R.
    Vander Heiden, Matthew G.
    Fiorentino, Michelangelo
    Giovannucci, Edward L.
    Loda, Massimo
    Mucci, Lorelei A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (02) : 193 - 200
  • [40] Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
    Soller, Maria Johansson
    Elfving, Peter
    Lundgren, Rolf
    Panagopols, Ioannis
    GENES CHROMOSOMES & CANCER, 2006, 45 (07): : 717 - 719
12345